Ben Lamm and George Church have secured a $3.8 billion valuation for their new company, Astromech, which aims to predict biological changes using genomic data and AI. This development is significant as it leverages advanced computational tools to forecast biological trends across various industries, potentially transforming how we approach health, biosecurity, agriculture, and conservation. Investors are betting on the founders' proven ability to translate complex scientific ideas into practical applications.
Read the full article at Digital Journal
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



